Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) EBT Margin: 2009-2019

Historic EBT Margin for Neurocrine Biosciences (NBIX) over the last 10 years, with Dec 2019 value amounting to 5.91%.

  • Neurocrine Biosciences' EBT Margin rose 3239.00% to 10.30% in Q3 2021 from the same period last year, while for Sep 2021 it was 5.43%, marking a year-over-year decrease of 451.00%. This contributed to the annual value of 5.91% for FY2019, which is 106.00% up from last year.
  • Neurocrine Biosciences' EBT Margin amounted to 5.91% in FY2019, which was up 22.00% from 4.84% recorded in FY2018.
  • In the past 5 years, Neurocrine Biosciences' EBT Margin ranged from a high of 5.91% in FY2019 and a low of -950.28% during FY2017.
  • Over the past 3 years, Neurocrine Biosciences' median EBT Margin value was 4.84% (recorded in 2018), while the average stood at -313.18%.
  • Its EBT Margin has fluctuated over the past 5 years, first plummeted by 47,457bps in 2016, then soared by 95,512bps in 2018.
  • Over the past 5 years, Neurocrine Biosciences' EBT Margin (Yearly) stood at -466.03% in 2015, then tumbled by 47,457bps to -940.60% in 2016, then slumped by 968bps to -950.28% in 2017, then spiked by 95,512bps to 4.84% in 2018, then spiked by 106bps to 5.91% in 2019.